Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WINNIE COMMUNITY HOSPITAL, L.L.C.

NPI: 1376937003 · VIDOR, TX 77662 · Family Nurse Practitioner · NPI assigned 03/19/2015

$455K
Total Medicaid Paid
35,394
Total Claims
30,887
Beneficiaries
49
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialJAVED, MUHAMMAD (CEO)
Parent OrganizationWINNIE COMMUNITY HOSPITAL LLC
NPI Enumeration Date03/19/2015

Related Entities

Other providers sharing the same authorized official: JAVED, MUHAMMAD

ProviderCityStateTotal Paid
MERIT MEDICAL RURAL HEALTH CLINIC-RICHLANDS, INC. RICHLANDS VA $427K
MUHAMMAD R. JAVED MD PC RICHLANDS VA $31K
RICELAND URGENT CARE STAFFORD TX $653.94

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 301 $4K
2019 277 $4K
2020 2,331 $17K
2021 5,326 $86K
2022 4,727 $114K
2023 11,640 $122K
2024 10,792 $107K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6,956 5,898 $264K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,358 3,751 $124K
99307 4,967 4,875 $26K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 278 272 $11K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 146 132 $7K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 99 92 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 126 118 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 382 291 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 148 138 $3K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 66 63 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 73 69 $854.14
99215 Prolong outpt/office vis 14 12 $827.50
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 36 32 $822.36
83037 131 120 $538.05
81002 92 83 $184.47
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 37 34 $164.30
99308 Subsequent nursing facility care, per day, straightforward 209 208 $106.63
3044F 14 14 $80.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 27 26 $54.18
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 13 13 $40.64
82948 19 16 $24.12
36415 Collection of venous blood by venipuncture 1,341 1,223 $12.75
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 52 46 $0.01
G8510 Screening for depression is documented as negative, a follow-up plan is not required 32 28 $0.01
1159F 3,393 2,765 $0.00
3078F 65 58 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 2,056 1,721 $0.00
1160F 3,546 2,885 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 308 282 $0.00
3028F 419 379 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 48 44 $0.00
3077F 57 53 $0.00
3008F 443 401 $0.00
3074F 57 50 $0.00
1125F 1,368 1,215 $0.00
1126F 2,419 2,031 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 130 119 $0.00
2001F 458 412 $0.00
3080F 31 30 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 71 62 $0.00
2000F 474 429 $0.00
96127 188 170 $0.00
4010F 31 29 $0.00
1036F 94 84 $0.00
1170F 13 12 $0.00
99484 17 16 $0.00
3048F 31 29 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 32 28 $0.00
96156 29 29 $0.00